BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 27, 2016
View Archived Issues
Novo Nordisk announces the launch of Tresiba in the U.S.
Read More
A new patent listed and additional orphan drug designation granted for Procysbi in the U.S.
Read More
Factor VII deficiency corrected with gene therapy in large animal model
Read More
OncoTherapy begins phase Ib trials of peptide vaccine for malignant mesothelioma
Read More
Cleveland BioLabs starts a phase II trial of CBLB-612 in the Russian Federation
Read More
Novavax announces proposed offering of USD 200 million convertible senior notes
Read More
CE Mark for Quidel's Sofia S. pneumoniae Fluorescent Immunoassay
Read More
Faron Pharmaceuticals listed in London Stock Exchange AIM market
Read More
Living Cell Technologies reports findings from phase I/IIa study of NTCell for Parkinson's disease
Read More
FDA approves Dako's PD-L1 IHC 28-8 pharmDx test for use in melanoma
Read More
FDA clearance for ChloraDerm antimicrobial film dressing
Read More
CMV vaccine is safe and effective in stem cell transplant patients
Read More
Study unveils the potential of exosomes as therapeutic agents and delivery system for gene therapies
Read More
Ferring Pharmaceuticals and Karolinska Institutet to establish human microbiome research center
Read More
Afatinib demonstrates superiority to gefitinib on PFS in LUX-Lung 7 trial
Read More
Johnson & Johnson reflects on highlights of fourth quarter 2015
Read More
University of Texas System patents mitochondrial GLS1 inhibitors
Read More
Transplanted pancreatic beta-like cells exhibited glucose-stimulated insulin secretion in mice
Read More
FDA puts Medivation's pidilizumab on clinical hold
Read More
BBI-608 plus paclitaxel shows promise for the treatment of refractory pancreatic cancer
Read More
Prima BioMed starts phase I study of IMP-321 for the treatment of melanoma
Read More